Persistent SARS-CoV-2 infection with repeated clinical recurrence in a patient with common variable immunodeficiency

Autor: Cabañero-Navalon MD, Garcia-Bustos V, Ruiz-Rodriguez P, Comas I, Coscollá M, Martinez-Priego L, Todolí J, Moral PM

Publikováno v: CLINICAL MICROBIOLOGY AND INFECTION
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::590d4ff05d882427b7acf114058d888f
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15154

The impact of immune dysregulation on the risk of malignancy in common variable immunodeficiency: insights from a multicenter study.

Autor: Cabañero-Navalon MD; Primary Immunodeficiencies Unit, Department of Internal Medicine, University and Polytechnic Hospital La Fe, Valencia, Spain.; Research Group of Chronic Diseases and HIV Infection, Health Research Institute La Fe, Valencia, Spain., Garcia-Bustos V; Primary Immunodeficiencies Unit, Department of Internal Medicine, University and Polytechnic Hospital La Fe, Valencia, Spain.; Severe Infection Research Group, Health Research Institute La Fe, Valencia, Spain., Balastegui-Martin H; Primary Immunodeficiencies Unit, Department of Internal Medicine, University and Polytechnic Hospital La Fe, Valencia, Spain.; Research Group of Chronic Diseases and HIV Infection, Health Research Institute La Fe, Valencia, Spain., Bracke C; Infectious Diseases Service, Germans Trias i Pujol Hospital, Badalona, Spain.; Fight Infections Foundation, Germans Trias i Pujol Hospital, Badalona, Spain., Mateu L; Infectious Diseases Service, Germans Trias i Pujol Hospital, Badalona, Spain.; Fight Infections Foundation, Germans Trias i Pujol Hospital, Badalona, Spain., Solanich X; Internal Medicine Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Translational Medicine Area, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain.; Department of Clinical Sciences, Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain., Carrillo-Linares JL; Department of Internal Medicine, Virgen de la Victoria University Hospital, Málaga, Spain., Robles-Marhuenda A; Department of Internal Medicine, La Paz University Hospital, Madrid, Spain., Puchades F; Department of Internal Medicine, University General Hospital of Valencia, Valencia, Spain., Pelaez Ballesta A; Department of Internal Medicine, Rafael Méndez University Hospital, Murcia, Spain., Lopez-Osle N; Department of Internal Medicine, Cruces University Hospital, Bizkaia, Bilbao, Spain., Torralba-Cabeza MÁ; Unit for Rare Diseases, Internal Medicine Service, Lozano Blesa University Hospital, Zaragoza, Spain., Bielsa Masdeu AM; Department of Internal Medicine, Miguel Servet University Hospital, Zaragoza, Spain., Gil Niño J; Immunodeficiencies clinic, Internal Medicine Department, 12 de Octubre Hospital, Madrid, Spain., Tornador Gaya N; Department of Internal Medicine, University General Hospital of Castellón, Castellón, Castellon, Spain., Castellanos GP; Department of Internal Medicine, University General Hospital of Castellón, Castellón, Castellon, Spain., Sánchez-Martínez R; Internal Medicine Department, Dr. Balmis General University Hospital, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain., Barragán-Casas JM; Department of Internal Medicine, Complejo Asistencial de Ávila, Ávila, Spain., González-García A; Systemic Autoimmune Diseases Unit, Internal Medicine Service, Ramón y Cajal Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Patier de la Peña JL; Systemic Autoimmune Diseases Unit, Internal Medicine Service, Ramón y Cajal Hospital, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., López-Wolf D; Department of Internal Medicine, University Hospital Alcorcón Foundation, Madrid, Spain., Rufete AM; Department of Internal Medicine, General University Hospital of Elche, Alicante, Spain., Canovas Mora A; Department of Internal Medicine, General University Hospital of Elche, Alicante, Spain., Moral Moral P; Primary Immunodeficiencies Unit, Department of Internal Medicine, University and Polytechnic Hospital La Fe, Valencia, Spain.; Research Group of Chronic Diseases and HIV Infection, Health Research Institute La Fe, Valencia, Spain.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Oct 16; Vol. 15, pp. 1465159. Date of Electronic Publication: 2024 Oct 16 (Print Publication: 2024).

Host-pathogen interactions upon Candida auris infection: fungal behaviour and immune response in Galleria mellonella .

Autor: Garcia-Bustos V; Department of Internal Medicine and Infectious Diseases, University and Polytechnic La Fe Hospital, Valencia, Spain.; Severe Infection Research Group, Health Research Institute La Fe, Valencia, Spain.; Department of Pathology, Faculty of Medicine and Dentistry, University of Valencia, Valencia, Spain., Pemán J; Severe Infection Research Group, Health Research Institute La Fe, Valencia, Spain.; Department of Medical Microbiology, University and Polytechnic La Fe Hospital, Valencia, Spain., Ruiz-Gaitán A; Severe Infection Research Group, Health Research Institute La Fe, Valencia, Spain., Cabañero-Navalon MD; Department of Internal Medicine and Infectious Diseases, University and Polytechnic La Fe Hospital, Valencia, Spain., Cabanilles-Boronat A; Department of Pathology, Faculty of Medicine and Dentistry, University of Valencia, Valencia, Spain., Fernández-Calduch M; Department of Pathology, Faculty of Medicine and Dentistry, University of Valencia, Valencia, Spain., Marcilla-Barreda L; Department of Pathology, Faculty of Medicine and Dentistry, University of Valencia, Valencia, Spain., Sigona-Giangreco IA; Severe Infection Research Group, Health Research Institute La Fe, Valencia, Spain.; Department of Medical Microbiology, University and Polytechnic La Fe Hospital, Valencia, Spain., Salavert M; Department of Internal Medicine and Infectious Diseases, University and Polytechnic La Fe Hospital, Valencia, Spain.; Severe Infection Research Group, Health Research Institute La Fe, Valencia, Spain., Tormo-Mas MÁ; Severe Infection Research Group, Health Research Institute La Fe, Valencia, Spain., Ruiz-Saurí A; Department of Pathology, Faculty of Medicine and Dentistry, University of Valencia, Valencia, Spain.

Publikováno v: Emerging microbes & infections [Emerg Microbes Infect] 2022 Dec; Vol. 11 (1), pp. 136-146.

Tedizolid: new data and experiences for clinical practice.

Autor: Salavert Lletí M; Miguel Salavert, Unidad de Enfermedades Infecciosas. Hospital Universitario y Politécnico La Fe, Valencia. Spain. salavert_mig@gva.es., García-Bustos V, Morata Ruiz L, Cabañero-Navalon MD

Publikováno v: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia [Rev Esp Quimioter] 2021 Sep; Vol. 34 Suppl 1, pp. 22-25. Date of Electronic Publication: 2021 Sep 30.

A clinical predictive model of candidaemia by Candida auris in previously colonized critically ill patients.

Autor: Garcia-Bustos V; Department of Internal Medicine, University and Polytechnic La Fe Hospital, Valencia, Spain. Electronic address: victorgarciabustos@gmail.com., Salavert M; Unit of Infectious Diseases, University and Polytechnic La Fe Hospital, Valencia, Spain., Ruiz-Gaitán AC; Department of Medical Microbiology, University and Polytechnic La Fe Hospital, Valencia, Spain., Cabañero-Navalon MD; Department of Internal Medicine, University and Polytechnic La Fe Hospital, Valencia, Spain., Sigona-Giangreco IA; Department of Medical Microbiology, University and Polytechnic La Fe Hospital, Valencia, Spain., Pemán J; Department of Medical Microbiology, University and Polytechnic La Fe Hospital, Valencia, Spain.

Publikováno v: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2020 Nov; Vol. 26 (11), pp. 1507-1513. Date of Electronic Publication: 2020 Mar 10.